d srinivas's most recent trade in Vilin Bio Med Ltd. was a Sell of 207,957 Equity Shares done at an average price of Rs. 20.3 . Disclosure was reported to the exchange on Dec. 31, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
d srinivas's has made SAST transactions in Vilin Bio Med Ltd. recently where a Sale of 207,957 Equity shares done . Disclosure was reported to the exchange on Dec. 31, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vilin Bio Med | Srinivasa Reddy Devireddy | Promoter | Sale | 31 Dec 2025 | 207,957 | 1,760,838 | - | - | 29 Dec 2025 29 Dec 2025 |
SAST (Reg29(2)) | Equity shares | Others | |
| Vilin Bio Med | Srinivasa Reddy Devireddy | Promoter | Sale | 31 Dec 2025 | 207,957 | 1,760,838 | - | - | 29 Dec 2025 29 Dec 2025 |
SAST (Reg29(2)) | Equity shares | Others | |
| Vilin Bio Med | Srinivasa Reddy Devireddy | Promoters | Sell | 31 Dec 2025 | 207,957 | 1,760,838 | - | 20.3 | 4,221,527 | 29 Dec 2025 29 Dec 2025 |
Insider Trading (-) | Equity Shares | Off Market |
| Shankara Building | Dhananjay Mirlay Srinivas | Promoter Group | Acquisition | 30 Mar 2023 | 5,500 | 81,050 (0.35%) | 0.02% | 621.8 | 3,420,065 | 29 Mar 2023 29 Mar 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Shankara Building | Dhananjay Mirlay Srinivas | Promoter Group | Acquisition | 29 Mar 2023 | 5,000 | 75,550 (0.33%) | 0.02% | 610.0 | 3,049,850 | 28 Mar 2023 28 Mar 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Shankara Building | Dhananjay Mirlay Srinivas | Promoter Group | Acquisition | 28 Mar 2023 | 10,000 | 70,550 (0.30%) | 0.04% | 641.6 | 6,416,400 | 27 Mar 2023 27 Mar 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 23 Jun 2022 | 1,000 | 0 (0%) | 0.00% | 2676.4 | 2,676,370 | 22 Jun 2022 22 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 23 Jun 2022 | 100 | 1,000 (0%) | 0.00% | 2653.6 | 265,357 | 21 Jun 2022 21 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 21 Jun 2022 | 500 | 1,100 (0%) | 0.00% | 2660 | 1,330,000 | 16 Jun 2022 16 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 17 Jun 2022 | 500 | 1,600 (0%) | 0.00% | 2702.1 | 1,351,070 | 15 Jun 2022 15 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Acquisition | 04 May 2022 | 2,100 | 2,100 (0%) | 0.00% | 542 | 1,138,200 | 29 Apr 2022 29 Apr 2022 |
Insider Trading | Equity Shares | ESOP |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 11 Aug 2021 | 4,550 | 350 (0%) | 0.00% | 4040 | 18,382,000 | 09 Aug 2021 09 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Gland Pharma | D SRINIVASA RAO | Designated Person | Disposal | 11 Aug 2021 | 350 | 0 (0%) | 0.00% | 4227.5 | 1,479,632 | 10 Aug 2021 10 Aug 2021 |
Insider Trading | Equity Shares | Market Sale |
| Neuland Laboratories | SRINIVASA KRISHNA MOHAN DAVULURI | Designated Person | Disposal | 10 Feb 2021 | 1,000 | 0 (0%) | 0.01% | 1687.8 | 1,687,752 | 05 Feb 2021 10 Feb 2021 |
Insider Trading | Equity Shares | Market Sale |